v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock and Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024   47,823    
Beginning balance at Dec. 31, 2024 $ 2,951,125 $ 706,817 $ 2,292,819 $ (48,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 270,061   270,061  
Other comprehensive income 24,820     24,820
Dividends and dividend equivalents declared (151,801)   (151,801)  
Common stock issued (in shares)   73    
Common stock issued $ 5,335 $ 5,335    
Repurchases of common stock (in shares) (4,000) (4)    
Repurchases of common stock $ (2,484) $ (2,484)    
Stock-based compensation expense 112,914 $ 112,914    
Ending balance (in shares) at Jun. 30, 2025   47,892    
Ending balance at Jun. 30, 2025 3,209,970 $ 822,582 2,411,079 (23,691)
Beginning balance (in shares) at Mar. 31, 2025   47,877    
Beginning balance at Mar. 31, 2025 3,073,629 $ 764,959 2,351,994 (43,324)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 135,009   135,009  
Other comprehensive income 19,633     19,633
Dividends and dividend equivalents declared (75,924)   (75,924)  
Common stock issued (in shares)   19    
Common stock issued $ 0      
Repurchases of common stock (in shares) (4,000) (4)    
Repurchases of common stock $ (2,484) $ (2,484)    
Stock-based compensation expense 60,107 $ 60,107    
Ending balance (in shares) at Jun. 30, 2025   47,892    
Ending balance at Jun. 30, 2025 $ 3,209,970 $ 822,582 2,411,079 (23,691)
Beginning balance (in shares) at Dec. 31, 2025 48,709 48,709    
Beginning balance at Dec. 31, 2025 $ 3,531,497 $ 936,998 2,609,651 (15,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 450,524   450,524  
Other comprehensive income 15,661     15,661
Dividends and dividend equivalents declared (198,322)   (198,322)  
Common stock issued (in shares)   436    
Common stock issued $ 5,830 $ 5,830    
Repurchases of common stock (in shares) (3,000) (3)    
Repurchases of common stock $ (4,048) $ (4,048)    
Stock-based compensation expense $ 94,282 $ 94,282    
Ending balance (in shares) at Jun. 30, 2026 49,142 49,142    
Ending balance at Jun. 30, 2026 $ 3,895,424 $ 1,033,062 2,861,853 509
Beginning balance (in shares) at Mar. 31, 2026   49,129    
Beginning balance at Mar. 31, 2026 3,677,410 $ 983,926 2,703,596 (10,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 257,298   257,298  
Other comprehensive income 10,621     10,621
Dividends and dividend equivalents declared (99,041)   (99,041)  
Common stock issued (in shares)   16    
Common stock issued $ 0      
Repurchases of common stock (in shares) (3,000) (3)    
Repurchases of common stock $ (4,048) $ (4,048)    
Stock-based compensation expense $ 53,184 $ 53,184    
Ending balance (in shares) at Jun. 30, 2026 49,142 49,142    
Ending balance at Jun. 30, 2026 $ 3,895,424 $ 1,033,062 $ 2,861,853 $ 509